Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New method for salt preparation

A technology of hydrochloric acid and acid addition salt, which is applied to the preparation and crystallization of hydrohalides of pharmaceutical compounds or their intermediates, in the field of industrial application, which can solve the problems of preferential formation, uneasy control, difficult operation, etc., and achieve good yields Effect

Inactive Publication Date: 2009-07-15
SANDOZ LTD
View PDF12 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

While the preferential formation of the desired form of the hydrochloride depends on the crystallization kinetics and is not easy to control
A constant flow of gaseous hydrogen chloride is sometimes necessary for a certain period of time and the temperature must be kept substantially constant during the gas flow and even during the filtration of the product, making the process extremely difficult to operate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New method for salt preparation
  • New method for salt preparation
  • New method for salt preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0244] Preparation of anhydrous crystal form of mycophenolate mofetil hydrochloride

[0245] 2 g (4.61 mmol) of mycophenolate mofetil base were dissolved in 50 ml of ethyl acetate at room temperature. To this solution were added 0.3 ml (1.2 equiv.) of acetic acid and 0.7 ml (1.2 equiv.) of trimethylchlorosilane with stirring. After 2 minutes at room temperature, crystallization started. The suspension was stirred for 1 hour and the precipitate was filtered off. The solid was washed with ethyl acetate and dried under vacuum at room temperature to afford 2.11 g (97.6%) of mycophenolate mofetil hydrochloride.

[0246] mp. = 157.2°C.

[0247] XRD pattern of mycophenolate mofetil hydrochloride Figure 1A and corresponds to the anhydrous crystalline form with X-ray crystallographic data as shown in WO95 / 07902. The infrared spectrum obtained as Figure 1B shown in .

[0248] The DSC of mycophenolate mofetil hydrochloride shows an endothermic peak at about 159°C (onset temperatu...

Embodiment 2

[0250] Preparation of venlafaxine hydrochloride

[0251] The preparation of embodiment 2.a venlafaxine hydrochloride crystal form I

[0252] 0.4 g (1.44 mmol) of venlafaxine base were dissolved in 10 ml of ethyl acetate at room temperature. To this solution was added 0.1 ml (1.1 equiv.) of acetic acid and 0.2 ml (1.1 equiv.) of trimethylchlorosilane with stirring. After 2 minutes at room temperature, crystallization started. The suspension was stirred for 30 minutes and the precipitate was filtered off. The solid was washed with ethyl acetate and dried under vacuum at room temperature to afford 0.41 g (89.1%) of venlafaxine hydrochloride.

[0253] mp. = 208°C.

[0254] XRD pattern of venlafaxine hydrochloride crystal form I Figure 2A and corresponds to Form I with X-ray crystallographic data as shown in US03 / 0114536.

[0255] The infrared spectrum obtained as Figure 2B shown in .

[0256] Embodiment 2.b Preparation of venlafaxine hydrochloride crystal form II

[025...

Embodiment 3

[0264] Preparation of Sertraline Hydrochloride Form II Using Sertraline Base

[0265] Example 3.a

[0266] 3 g (9.8 mmol) sertraline base was dissolved in 60 ml acetonitrile at room temperature. To this solution were added 0.6 ml (1 eq) of acetic acid and 1.4 ml (1.1 eq) of trimethylchlorosilane with stirring. Sertraline hydrochloride precipitated out exactly in crystalline form II at the same time as the addition. After stirring the suspension for 1 hour, the product was filtered off and dried at 50° C. for 3 hours to afford 3.2 g (95.3%) of crystalline sertraline hydrochloride Form II.

[0267] mp.: 252°C.

[0268] The obtained XRD pattern is as follows Figure 4A shown in and corresponds to pure Form II.

[0269] The infrared spectrum obtained as Figure 4B shown in .

[0270] Example 3.b

[0271] 3 g (9.8 mmol) of sertraline base were dissolved in a mixture of 60 ml of acetonitrile and 1 ml of n-butanol. The solution was heated to 50 °C and 1.4 ml (1.1 eq) trimeth...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a new method for preparation and crystallization of hydrochlorides, hydrobromides or hydroiodides of pharmaceutical compounds or their intermediates in which the base or its acid addition salt is reacted in a solvent with a Trialkylsilylhalogenide.

Description

field of invention [0001] The present invention provides novel methods for the preparation and crystallization of hydrohalides of pharmaceutical compounds or intermediates thereof. According to this method, the hydrohalides can be obtained in a reliable manner in good yields and in pure form consisting of defined crystal structures. The method of the invention is particularly well suited for industrial applications. Background of the invention [0002] Hydrohalides of pharmaceutical compounds or intermediates thereof are generally prepared by acidifying solutions of bases or salts with hydrogen chloride, either in aqueous solution or gaseous hydrogen chloride or HCl in an organic solvent. The preparation of the hydrochloride salt by addition of aqueous hydrochloric acid is a straightforward method and is conveniently used as a 36% (w / w) solution in water. The typical approach is to dissolve the organic base in a solvent and add a calculated volume or excess of concentrated...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C209/74
CPCC07D211/32C07C209/68C07D471/04C07D333/56C07D277/82C07D307/87C07D215/56C07D263/24C07D409/06C07D333/16C07C213/02C07D405/06C07D239/94C07D307/88C07D487/04C07D231/14C07D215/227A61P5/14C07C211/38C07C211/42C07C217/74
Inventor J·威瑟尔H·伦加尔E·克灵勒尔A·皮希勒H·斯图尔姆
Owner SANDOZ LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com